KEFORAL 250 mg/5 ml, powder for oral suspension in a vial bottle, 39.6 g
Active ingredients: Cephalexin monohydrate
Commercialized according to BDPMDispensing in France: Prescription only
Powder for oral suspensionbottle, 39.6 gorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- KEFORAL 250 mg/5 ml, poudre pour suspension buvable en flacon
- Pharmaceutical form
- poudre pour suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène de 39,6 g avec cuillère-mesure
- Marketing authorisation holder
- SCIENCEX
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 30 Jun 2005
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61386381CIP73212145CIP133400932121458Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CÉFALEXINE MONOHYDRATÉEpoudre | 250 mg · une cuillère-mesure de 5 ml après reconstitution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.